Erdheim-Chester disease: The power of nuclear medicine imaging

Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Sep-Oct;39(5):323-324. doi: 10.1016/j.remn.2020.01.003. Epub 2020 Jun 29.

[Article in English, Spanish]

Authors

E Cerudelli¹, M Gazzilli², M Bertoli², F Bertagna³, R Giubbini³

Affiliations

¹ Department of Nuclear Medicine, ASST Spedali Civili, Brescia, Italia. Electronic address: elisabetta.cerudelli@gmail.com.
² Department of Nuclear Medicine, ASST Spedali Civili, Brescia, Italia.
³ Department of Nuclear Medicine, ASST Spedali Civili, Brescia, Italia; Università degli Studi di Brescia, Brescia, Italia.

PMID: 32616456
DOI: 10.1016/j.remn.2020.01.003

No abstract available

Publication types

Case Reports

MeSH terms

Adipose Tissue / pathology
Aged
Arthralgia / diagnostic imaging*
Arthralgia / etiology
Diagnosis, Differential
Erdheim-Chester Disease / complications
Erdheim-Chester Disease / diagnosis
Erdheim-Chester Disease / diagnostic imaging*
Erdheim-Chester Disease / pathology
Female
Femur / diagnostic imaging*
Fluorine Radioisotopes
Fluorodeoxyglucose F18
Histiocytes / chemistry
Histiocytes / pathology
Humans
Image-Guided Biopsy*
Mutation
Nasal Bone / diagnostic imaging
Osteitis Deformans / diagnosis
Osteolysis / diagnostic imaging
Osteolysis / etiology
Positron Emission Tomography Computed Tomography*
Proto-Oncogene Proteins B-raf / genetics
Radionuclide Imaging*
Radiopharmaceuticals
Technetium Tc 99m Medronate
Tibia / diagnostic imaging*
Vasculitis / diagnosis

Substances

Fluorine Radioisotopes
Radiopharmaceuticals
Fluorodeoxyglucose F18
BRAF protein, human
Proto-Oncogene Proteins B-raf
Fluorine-18
Technetium Tc 99m Medronate